Skip to search formSkip to main contentSkip to account menu

NP-59

Known as: NP59 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
PurposePrimary aldosteronism (PA), characterized by an excessive production of aldosterone, affects 5−13 % of patients with… 
1998
1998
Adrenal scintigraphy with 131I-labeled 6-beta-iodomethyl-19-norcholesterol (NP-59) is a technically demanding and complex… 
Highly Cited
1998
Highly Cited
1998
UNLABELLED The goal of this study was to examine the clinical and economic outcomes of alternative diagnostic strategies for… 
1998
1998
Adrenocortical scintigraphy is a useful technique for differentiating between types of nonhyperfunctioning adrenal masses… 
1986
1986
The enterohepatic circulation and distribution of 131I-6β-iodomethyl-19-norcholesterol (NP-59) was assessed in a rabbit model to… 
1983
1983
The use of radiolabeled cholesterol derivatives for functional imaging of the adrenal cortex may be rendered inaccurate or… 
1983
1983
Referral patterns from internists to departments of nuclear medicine or radiology are important determinants of whether adrenal… 
1979
1979
Twenty consecutive patients with primary aldosteronism (PAl) underwent dexamethasone suppression (DS) imaging with 6beta-[131I… 
1979
1979
To establish the parameters of adrenal imaging under dexamethasone suppression (DS), 18 normotensive, normal male volunteers…